Plasma-Activated Water for fibromyalgia symptoms
Official title: The Potential Application of Plasma-Activated Water in Fibromyalgia Patients
Run by Taipei Medical University · NCT07659236 · Data updated 2026-11-12
This study tests whether drinking plasma-activated water can help reduce widespread pain and related symptoms in adults with fibromyalgia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 75 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Taipei Medical University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | July 1, 2024 |
| Main results expected | July 31, 2026 |
| Study ends | July 31, 2026 |
| Registry record updated | June 22, 2026 |
| Trial ID | NCT07659236 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 20 to 75 with a clinical diagnosis of fibromyalgia and chronic widespread pain, able to communicate in Mandarin or a Taiwanese dialect.
✕Probably not a fit
Individuals with malignant tumors, acute infections, CNS or endocrine disorders, significant autoimmune diseases, or pregnancy may not benefit and could be excluded for safety.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares plasma-activated water to a placebo beverage in adults with fibromyalgia. Participants will have long-standing widespread pain and meet criteria for fibromyalgia, and will receive either the active or placebo drink over a defined period. The goal is to observe any changes in pain intensity and associated symptoms, while monitoring safety. The approach relies on a novel use of plasma-activated water as a potential dietary intervention. Overall, results will indicate whether this treatment is feasible and whether it shows signals of symptom improvement worth pursuing in larger trials.
Why it matters
Potential benefit: If successful, participants may experience reduced pain and improved quality of life related to fibromyalgia.
How similar studies have gone: This approach appears exploratory; there is limited prior evidence for plasma-activated water in fibromyalgia, making results uncertain but potentially informative.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Currently experiencing widespread bodily pain for a duration of at least three months and diagnosed by a clinical specialist as a fibromyalgia patient. 2. Aged between 20 and 75 years. 3. Clear understanding and the ability to communicate with the researchers in Mandarin or Taiwanese dialect through spoken or written language. 4. Willingness to participate in this research after receiving an explanation and the ability to cooperate with the research procedures. Exclusion Criteria: 1. Malignant tumors. 2. Currently experiencing an acute infection. 3. Concurrent central nervous system disorders such as stroke or Parkinson's disease. 4. Concurrent endocrine system disorders such as hypothyroidism. 5. Significant autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, lupus, and others. 6. Currently pregnant.
Where it's running
-
Taipei Medical University Hospital
Taipei, Taiwan Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nurse-guided app-based brief behavioral therapy for insomnia in older adults
Aging adults with insomnia will be asked to try a nurse-supported, smartphone app therapy for four weeks to see if it helps with sleep.
-
Low-Intensity Endurance Exercise to Help Lung Cancer-Related Fatigue
This trial tests whether light, regular endurance exercise can help reduce fatigue and improve quality of life for people with lung cancer in addition to their usual care.
-
Low-Intensity Endurance Exercise for Lung Cancer-Related Fatigue
A randomized trial tests whether light, regular endurance exercise can help reduce fatigue and improve quality of life for people with lung cancer.
-
Taiwan green propolis for MASLD and lipid/metabolic issues
This study tests whether Taiwan green propolis capsules can improve blood lipids and body fat in adults with MASLD compared to a placebo over 12 weeks.
-
Probiotic Y7 cocktail to help with early Parkinson’s symptoms
A 12-week randomized trial will test whether a probiotic Y7 cocktail helps people with early Parkinson’s disease by possibly improving motor, thinking, and everyday symptoms.
-
Prebiotic formulation and its effects on gut microbiota and body composition in adults
A prebiotic supplement (PI-YSP-0111) is being tested in healthy adults to see if 8 weeks of use can favorably change gut bacteria and body composition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.